Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant.
Rajasekar R, Lakshmi KM, George B, Viswabandya A, Thirugnanam R, Abraham A, Chandy M, Srivastava A, Mathews V. Rajasekar R, et al. Among authors: lakshmi km. Biol Blood Marrow Transplant. 2010 Jun;16(6):854-60. doi: 10.1016/j.bbmt.2010.01.013. Epub 2010 Feb 4. Biol Blood Marrow Transplant. 2010. PMID: 20138229 Free article. Clinical Trial.
A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation.
Mathews V, George B, Deotare U, Lakshmi KM, Viswabandya A, Daniel D, Chandy M, Srivastava A. Mathews V, et al. Among authors: lakshmi km. Biol Blood Marrow Transplant. 2007 Aug;13(8):889-94. doi: 10.1016/j.bbmt.2007.05.004. Epub 2007 Jun 22. Biol Blood Marrow Transplant. 2007. PMID: 17640592 Free article.
Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.
Rajasekar R, Mathews V, Lakshmi KM, Sellathamby S, George B, Viswabandya A, Daniel D, Chandy M, Srivastava A. Rajasekar R, et al. Among authors: lakshmi km. Biol Blood Marrow Transplant. 2008 Mar;14(3):344-50. doi: 10.1016/j.bbmt.2007.12.494. Biol Blood Marrow Transplant. 2008. PMID: 18275901 Free article.
Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
Rajasekar R, Mathews V, Lakshmi KM, George B, Viswabandya A, Chandy M, Srivastava A. Rajasekar R, et al. Among authors: lakshmi km. Biol Blood Marrow Transplant. 2009 May;15(5):597-609. doi: 10.1016/j.bbmt.2009.01.016. Biol Blood Marrow Transplant. 2009. PMID: 19361752 Free article. Clinical Trial.
Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R, George B, Chendamarai E, Lakshmi KM, Balasubramanian P, Viswabandya A, Srivastava A, Chandy M, Mathews V. Thirugnanam R, et al. Among authors: lakshmi km. Biol Blood Marrow Transplant. 2009 Nov;15(11):1479-84. doi: 10.1016/j.bbmt.2009.07.010. Epub 2009 Sep 1. Biol Blood Marrow Transplant. 2009. PMID: 19822309 Free article.
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data.
Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, Viswabandya A, Thirugnanam R, Abraham A, Shaji RV, Srivastava A, Chandy M. Mathews V, et al. Among authors: lakshmi km. J Clin Oncol. 2010 Aug 20;28(24):3866-71. doi: 10.1200/JCO.2010.28.5031. Epub 2010 Jul 19. J Clin Oncol. 2010. PMID: 20644086 Clinical Trial.
74 results